Bosh sahifaIOVA โข NASDAQ
add
Iovance Biotherapeutics Inc
2,44ย $
Dastlabki sotuv:(0,00%)0,00
2,44ย $
Yopilgan:21-yan, 8:18:39 (GMT-5) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
2,36ย $
Kunlik diapazon
2,24ย $ - 2,56ย $
Yillik diapazon
1,64ย $ - 6,50ย $
Bozor kapitalizatsiyasi
968,60ย mln USD
Oสปrtacha hajm
12,21ย mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 67,46ย mln | 15,20% |
Joriy xarajat | 118,74ย mln | 2,27% |
Sof foyda | -91,25ย mln | -9,23% |
Sof foyda marjasi | -135,28 | 5,18% |
Har bir ulushga tushum | -0,25 | 10,71% |
EBITDA | -81,00ย mln | 0,62% |
Amaldagi soliq stavkasi | 2,57% | โ |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 300,80ย mln | -24,32% |
Jami aktivlari | 904,95ย mln | -8,69% |
Jami passivlari | 202,66ย mln | -6,89% |
Umumiy kapital | 702,29ย mln | โ |
Tarqatilgan aksiyalar | 396,97ย mln | โ |
Narxi/balansdagi bahosi | 1,30 | โ |
Aktivlardan daromad | -24,76% | โ |
Kapitaldan daromad | -29,79% | โ |
Pul aylanmasi
Naqd pulning sof oสปzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -91,25ย mln | -9,23% |
Operatsiyalardan naqd pul | -78,70ย mln | -33,45% |
Sarmoyadan naqd pul | 17,01ย mln | 134,86% |
Moliyadan naqd pul | 88,06ย mln | 109,89% |
Naqd pulning sof oสปzgarishi | 25,69ย mln | 139,78% |
Boสปsh pul | -52,92ย mln | -121,55% |
Haqida
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
Tashkil etilgan
2007
Sayt
Xodimlar soni
838
